RxSight (RXST) Operating Leases (2020 - 2025)
RxSight (RXST) has disclosed Operating Leases for 6 consecutive years, with $9.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Operating Leases fell 12.75% year-over-year to $9.9 million, compared with a TTM value of $9.9 million through Dec 2025, down 12.75%, and an annual FY2025 reading of $9.9 million, down 12.75% over the prior year.
- Operating Leases was $9.9 million for Q4 2025 at RxSight, down from $10.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $11.3 million in Q4 2024 and bottomed at $908000.0 in Q1 2024.
- Average Operating Leases over 5 years is $5.7 million, with a median of $3.9 million recorded in 2022.
- The sharpest move saw Operating Leases plummeted 61.16% in 2024, then skyrocketed 1110.02% in 2025.
- Year by year, Operating Leases stood at $3.6 million in 2021, then dropped by 21.58% to $2.9 million in 2022, then crashed by 57.6% to $1.2 million in 2023, then soared by 834.93% to $11.3 million in 2024, then fell by 12.75% to $9.9 million in 2025.
- Business Quant data shows Operating Leases for RXST at $9.9 million in Q4 2025, $10.3 million in Q3 2025, and $10.6 million in Q2 2025.